North America Immunohematology Market size surpassed USD 840 million in 2021 and is expected to grow at 4% CAGR between 2022 and 2028. The growing number of blood transfusions across the region is supporting the market growth. In the United States, a patient needs blood about every two seconds. With the number of chronic illnesses, traumatic injuries, and cancer incidences on the rise, the need for plasma and blood donation is increasing.
Get more details on this report - Request Free Sample PDF
Medical facilities are focusing on the expansion of top-notch infrastructure across the U.S. as well as Canada. Recently, in October 2022, the Children's Oncology Hematologic Clinic (COHC), a subsidiary of KIDZ Medical Services, announced the inauguration of its new practice in West Palm Beach in Florida. The facility will provide specialized care to children and teenagers for lymphoma, leukemia, brain tumors, bone marrow-related illnesses, solid tumors, bone marrow transplants, and a host of blood disorders.
COVID-19 virus Impact on North America immunohematology market outlook
The novel coronavirus pandemic impacted the healthcare sector in many ways. There was increased need for developing effective diagnostic products. Manufacturers are introducing innovative devices that minimize dependence on skilled personnel. According to a pre-pandemic survey conducted by the American Society of Hematology (ASH), nearly half of the total number of practices and hospitals across the country were already short of skilled hematologists. With this situation being exacerbated by the outbreak of SARS-CoV-2, the ASH committed over USD 20 million to a training program for hematologists. With hematology research on the agenda of the organization, the emergence of cutting-edge technologies is on the horizon in academia and in the market.
North America Market, By Product
The analyzers & systems product segment accounted for USD 290 million revenue in 2021, owing the rising number of premature births and childbirth-related complications are fueling the need for better blood transfer infrastructure. Several hospitals in the U.S. are investing in these devices, as they help sustain the lives of not only new mothers but also their premature babies. The government is investing in the development of a robust, easily accessible blood supply throughout the national healthcare system.
North America Market, By Technology
The biochips segment in the North America immunohematology market will cross USD 130 million revenue by 2028. This technology is gaining traction with a rise in investments supporting DNA diagnostics that rely on these platforms. As investments in cancer and elderly patient care are growing, product manufacturers will profit from an abundance of market opportunities. Biochips offer benefits such as simultaneous qualitative or qualitative detection across a range of analytes from a single sample. The technology can assist in toxicological, biological and protein research, expanding the industry scope.
North America Immunohematology Market, By End-use
The diagnostic laboratories will witness a lucrative growth during the forecast timeframe. These facilities provide advantages such as fast results, ability to procure advanced equipment and wider access. The number patients with diseases such as HIV, anaemia, lymphoma, leukaemia, and myeloma is growing in North America. Higher awareness about early detection of these disorders will augment the demand for immunohematology products across diagnostic labs.
Competitive Industry Landscape
Some of the leading companies operating in the North America immunohematology market are Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, Abbott, Hologic, and Beckman Coulter.
Companies are joining hands to simplify laboratory operations and improve workflows. To cite an instance, in July 2022, Beckman Coulter, a top provider of clinical diagnostic solutions, announced that it has found a partnership with Scorpio Labs a MedTech company developing AI-powered workflow solutions. The new solution will eliminate dependence on manual microscopy by providing access to high-resolution full-field images that can be shared in real-time across the healthcare network.